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Abstract
Bcl-2 functions to repress apoptosis by regulation of genes which encode proteins required for
programmed cell death and by interference with peroxldatlve damage. We Investigated the
Interrelationship between expression of bcl-2 and regulation of transcription factor DNA binding
activities In the 2B4 T cell hybridoma and IL-2-dependent CTLL T cell line. Over-expression of bcl-2
in 2B4 resulted In enhanced basal levels of activator protein (AP)-1, octamer binding factor (Oct)-1,
lymphoid enhancer binding factor (LEF)-1, RelA-p50 and NF-KB p50-p50 DNA binding activities.
After apoptotic signaling, down-regulation of AP-1, NF-AT and Oct-1 binding activities was
observed In control 2B4 and CTLL, whereas suboptimal, but higher, levels of these transcription
factors were found in bc/-2-transfected cells, potentially promoting cell survival. Furthermore, after
apoptotic signaling, expression of bcl-2 led to differential changes of NF-KB levels, resulting in a
decrease In RelA-p50 and an increase in NF-KB p5O-p50, altering the ratio of these DNA binding
activities such that now p5O-p50 markedly predominated In both 2B4-Bcl-2 and CTLL-Bcl-2.
Apoptotic signaling in the presence or absence of Bcl-2 resulted In induction of the RelB-p50
heterodlmer In 2B4. The changes In NF-KB/RBI levels raise the possibility that this family of
transcription factors may play an Important role In the regulation of apoptosis.
Introduction
Antigen activation of T lymphocytes is accompanied by clonal
expansion of antigen-specific T cells and their differentiation
into effector cells, which are characterized by secretion of
cytokines or cytotoxic T lymphocyte activity. The production
of cytokines is dependent upon activation of T cell signaling
cascades, which in turn activate distinct transcription factors
that control cytokine gene expression. One well characterized
example is the IL-2 gene whose expression is controlled by
coordinate action of several transcription factors including
activator protein (AP)-1, NF-KB, NF-AT and octamer binding
protein (Oct)-1 (1,2).
The regulation of the NF-KB/Rel family of transcription
factors is of particular interest as these factors have been
implicated in the regulation of many genes after T cell
activation (3). Nuclear NF-KB is found as heterodimers of p50
or p52 subunits with three different m.embers of the Rel family:
RelA (p65), RelB and c-Rel (4). The activation of NF-KB p65-
p50 (or RelA-p50) is dependent upon release of p65-p50
from a complex with cytoplasmic inhibitor IKB (MAD-3) with
subsequent translocation of p65-p50 into the nucleus (5,6).
RelA is an extremely potent transcription activation subunit,
while the p50 and p52 subunits have a DNA binding domain
but no apparent frans-activator domain (3). NF-KB p50 may
form the homodimer complex (7), which only slightly activates
NF-tcB-dependent transcription in vitro (8,9), whereas both
p50-p50 and p52-p52 homodimers may function as negative
regulators in vivo (4,10-12). Two variables that are likely to
control the overall level of NF-KB-dependent transcription
in vivo are the nuclear ratio of NF-KB frans-activators (RelA-
p50, RelB-p50, c-Rel-p50) to NF-KB frans-inhibitors (p50-
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p50 and p52-p52) and the relative affinity of distinct NF-KB
binding sites for these transcription factors.
Another outcome of T cell activation is the induction of
apoptosis which may function to limit an antigen-specific T
cell response. It is likely that some of the same signaling
molecules and transcription factors that control T cell differen-
tiation and activation are also important participants in the
induction of the genes required for apoptosis. Several genes
have been implicated in regulation of apoptosis, some of
which encode cell surface receptors, e.g. the TNF receptor
and Fas, intracellular signaling molecules, or transcription
factors, e.g. c-Myc, p53 and Nur 77 (13-16). The protooncog-
ene bcl-2 encodes a 26 kDa membrane protein that functions
to inhibit many types of apoptotic cell death (17). The molecu-
lar mechanism, however, by which Bcl-2 inhibits apoptosis is
poorly understood. This protein may also function as an
intracellular antioxidant which prevents cell damage by
oxygen free radicals (18,19). It is conceivable that these two
functions of Bcl-2 are interrelated and the intracellular targets
for the antioxidant effect of Bcl-2 might also play a pivotal
role in the regulation of apoptosis. Two potential candidates
are transcription factors NF-KB and TCF1(a)/lymphoid
enhancer binding factor (LEF)-1 as a number of agents
with antioxidant activity effectively inhibit activation of these
transcription factors (3,20).
In the present study we have evaluated the interrelationship
between T cell activation and apoptosis by examining the
effect of Bcl-2 on several transcription factors that are normally
up-regulated upon T cell activation. We show that Bcl-2 has
pleiotropic effects on transcription factor binding activities,
including NF-KB, AP-1, Oct and LEF-1. After receiving apop-
totic signals, one target of Bcl-2 in T cells is the induction of




The 2B4 T cell hybridoma was cultured in RPMI 1640 medium
supplemented with 5% FCS, 50 mM 2-mercaptoethanol and
antibiotics. IL-2-dependent CTLL2 cells were cultured in the
same medium containing IL-2 (100 U/ml).
Transfected cell lines
CTLL2 cells were stably transfected with mouse bcl-2 cDNA
in expression vector pBMGneo (21) (CTLL-Bcl-2 cells) or
with the unmodified vector (CTLL-neo cells) as previously
described (22). 2B4 cells were transfected with bcl-2 cDNA
in the same vector by electroporation and selected for G418
resistance. A cell line with high-level expression of bcl-2
mRNA was established on the base of Northern blot analysis
(2B4-8cl-2). Control cells were 2B4 transfected with the vector
pBMGneo (2B4-neo). 2B4 clones were also stably transfected
with pRc/CMV-p50, a NF-KB p50 expression vector. This
construct was kindly provided by Dr A. Israel (Paris, France).
Cell cycle analysis
After fixation with 70% ethanol in PBS, cells were pelleted
and resuspended in 0.5 ml of PBS containing propidium
iodide (40 ng/ml) and DNase-free RNase A (100 ng/ml). Cells
were incubated at 37°C for 30 min and then analyzed in a
FACScan (Becton Dickinson, Mountain View, CA).
Antibodies
The mAb to the e chain of the TCR complex, anti-CD3e (145-
2C11), has been previously characterized (23). Polyclonal
rabbit antisera to the p50 subunit of NF-KB (10), to a N-
terminal peptide of the p65 subunit of NF-KB (24), to a C-
terminal peptide of c-Rel (25), to mouse RelB (26) and to
mouse LEF-1 (27) were kindly provided by Drs M. Lenardo
(Bethesda, MD), W. Greene (San Francisco, CA), N. Rice
(Frederick, MD), R. Bravo (Princeton, NJ) and R. Grosschedl
(San-Francisco, CA) respectively.
Oligonucleotides and electrophoretic mobility shift assay
(EMSA)
The following double-stranded oligonucleotides were used in
this study as specific probes for transcription factors (only
one strand of a double-stranded oligonucleotide is shown,








These oligonucleotides were end-labeled with [y-^PJATP
using T4 polynucleotide kinase. Nuclear extracts were pre-
pared from 5-15X106 T cells. Binding reactions were carried
out by incubating the end-labeled DNA (50,000 c.p.m.) with
5 ng of nuclear proteins and 2 ng of poly(dl-dC) as described
previously (20). For identification of transcription factors,
nuclear extracts were preincubated with 1.0 ^l of specific
antiserum for 15 min at 20°C before addition of the labeled
oligonucleotide probes. The incubation was continued for a
further 30 min followed by EMSA.
Transfection and chloramphenicol acetyltransferase (CAT)
assay
The following reporter CAT constructs were used in this study:
pll_2CAT (original name plLCAT2/1+) which contained the
regulatory region -2931-7 of mouse IL-2 gene (28 ); -121-
HIV-CAT which contained the region -121/+232 from the HIV
long terminal repeat with 2XNF-KB and 3xSP1 binding sites,
and -76-HIV-CAT with deleted NF-KB sites (29). T cells
growing in log phase were transfected by the DEAE-dextran
method. Reference plasmid pRSVpgal was used as a control
for transfection efficiency. For each transfection experiment
5X107 cells were treated with 50 ng reporter plasmid DNA,
10 ng pRSVPgal and 250 ng/ml DEAE-dextran. At 20 h after
transfection each cell culture was split into five 100 mm tissue
plates and stimulated with PMA (10 ng/ml) plus ionomycin (1
jiM), dexamethasone (Dex; 1|iM) or anti-CD3e as previously
described (30). After an additional 20 h of culture, transfected
cells were harvested and used for isolation of total cell
extracts. Protein concentration of cell extracts was normalized
on the basis of p-galactosidase activity of transfected unstimu-
lated cells to correct for transfection efficiency. Quantitation
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of CAT assays was performed by liquid scintillation counting
of the appropriate area from chromatography plates. Relative
CAT activity (or fold of induction) was determined as a ratio
of percentage of acetylated chloramphenicol for activated
cells to that percentage for control unstimulated cells.
Western blot analysis
Equal amounts of nuclear extract proteins (5 \ig) were separ-
ated by SDS-PAGE in 10% gels. After transferral to nitrocellu-
lose, the blots were blocked with 3% non-fat milk for 2 h and
incubated with specific antibody at a dilution 1.100 for an
additional 2 h at room temperature. After three washes with
TBST (10 mM Tris-HCI, pH 7.5, 140 mM NaCI, 0.1% Tween
20), filters were incubated with the secondary antibody (goat
anti-rabbit IgG, dilution 1:2500) for 1 h, then were washed
with TBST and finally incubated with 125l-labeled Protein G
(Sigma, St Louis, MO) for 1 h. After several washes with TBS,
filters were dried and exposed for 2-18 h at -80°C with
intensifying screens.
Northern hybridization analysis
Cytoplasmic cell extracts were used for isolation and purifica-
tion of total RNA. RNA was separated on formaldehyde/
MOPS agarose gel and blotted on Hybond N membranes
(Amersham, Arlington Heights, IL) which were hybridized with
32P-labeled DNA probes. NF-KB p105/p50 cDNA (7) was
kindly provided by Dr A. Israel.
Results
Transcription factor activities in 2B4 cells transfected with
bcl-2 cDNA
To begin to determine the molecular basis by which Bcl-2
prevents apoptotic cell death, the 2B4 T cell hybridoma
was stably transfected with bcl-2 cDNA in the pBMGneo
expression vector. Northern blot analysis of resulting drug-
resistant cells (2B4-Bcl-2) demonstrated high levels of expres-
sion of transfected bcl-2 mRNA when compared with 2B4
cells transfected only with the unmodified vector pBMGneo
(2B4-neo) that served as control cells in this study. The levels
of GAPDH mRNA were similar for both untreated cells,
indicating that electrophoretic lanes contained similar quantit-
ies of RNA. Interestingly, the levels of c-myc mRNA were
selectively enhanced in 2B4-Bcl-2 while levels of NF-KB p105
mRNA were similar for both cells (Fig. 1).
To determine the extent by which Bcl-2 affects gene expres-
sion, we examined DNA binding activity of several transcrip-
tion factors important for T cell activation in nuclear extracts
from 2B4-Bcl-2 and 2B4-neo by EMSA. Over-expression of
bcl-2 in unstimulated 2B4 cells enhanced the background
levels of AP-1, Oct-1, LEF-1, the upper and lower NF-KB
binding complexes, which were identified with specific anti-
sera as p65-p50 (RelA-p50) and p50-p50 complexes,
whereas cAMP response element binding protein (CREB) and
NF-Y levels were relatively stable (Fig. 2). Although the basal
levels of NF-KB p65-p50 were quite variable for 2B4-neo
cells, 2B4-Bcl-2 always contained higher basal levels of this
heterodimer. The second band detected with the NF-Y probe
in extracts from 2B4-Bcl-2 cells comprises an additional
DEX.
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Fig. 1. Time-course analysis of specific mRNA levels in 2B4-neo and
2B4-Bcl-2 cells after Dex treatment. Northern hybridization with
labeled probes for bcl-2, c-myc, NF-KB p105 and GAPDH mRNA
Total mRNA was isolated from 2X106 cells which were untreated (0)
or stimulated with 1 nM Dex for 4-16 h.
CCAAT binding protein immunochemically distinct from NF-
Y. The LEF-1 complex was identified by inhibition of DNA
binding with a specific antibody. The upper AP-1 complex
was identified by use of specific antibodies as a Jun-Fos
heterodimer whereas the lower AP-1 complex was a Jun-Jun
homodimer (data not shown). A 'non-canonical' octamer
binding site from the IL-2 promoter was used because this
probe may reveal more subtle differences in the regulation of
Oct factors than intact Oct probe. Oct-1 was the only factor
of the octamer binding protein family which was detected in
2B4-neo cells. For 2B4-Bcl-2 cells, a strong additional, but
non-specific, activity was detected, as shown by the absence
of competition with an unlabeled octamer oligonucleotide.
The significant finding from EMSA experiments was that the
over-expression of bcl-2 led to enhanced nuclear activity for
NF-KB p50-p50, p65-p50 and for several other factors without
external cellular activation. Over-expression of bcl-2 in the
EL4 thymoma cell line also up-regulated the basal level of
both NF-KB p50-p50 and p65-p50 (Fig. 2, lanes 5-7).
When compared with unstimulated cells, enhanced levels
of nuclear NF-KB p65-p50, p50-p50, AP-1, LEF-1 and Oct-1
were observed 6 h after activation of 2B4-neo and 2B4-Bcl-
2 by PMA and ionomycin. Activated 2B4-Bcl-2 cells contained
the highest levels of these DNA binding activities. Similar
results for NF-KB p65-p50 were observed after treatment of
these cells with anti-CD3e mAb (data not shown).
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Fig. 2. Nuclear transcription factors in control and bc/-2-transfected
2B4 and EL-4. EMSA were performed with nuclear extract proteins
(5 ug) from cells, that were not treated or stimulated for 6 h with PMA
(10 ng/ml) plus lonomycin (1 (iM), by use of labeled oligonucleotide
probes for specific transcription factors. Specific DNA binding
complexes are indicated by arrows. Bands of free labeled
oligonucleotide probes are not shown.
Selective regulation of transcription factor levels in 2B4-neo
and 2B4-Bcl-2 by Dex
Previous studies have demonstrated that Dex induces
apoptosis of 2B4 (31). Over-expression of bcl-2 in 2B4 inhibits
this apoptosis (18). Cell cycle analysis revealed that the
number of both 2B4-neo and 2B4-Bcl-2 cells in the S phase
was significantly reduced, whereas increased level of apop-
totic 2B4-neo with hypodiploid DNA content was detected
0 S00 409 608
Fluorescence Intensity
Fig. 3. Cell cycle analysis of 2B4-neo and 2B4-Bcl-2 cells after Dex
treatment. The DNA content in the cells was determined 0, 8 and 16 h
after Dex treatment by propidium iodide staining and flow cytometry.
Gates M1, M2, M3 and M4 identify apoptotic cells with hypodiploid
DNA content, stages G1f S and G2/M of the cell cycle respectively.
(Fig. 3, gate M1). At 16 h after treatment, 2B4-Bcl-2 were
viable but with cells arrested at G, and G2/M phases, while
>30% of 2B4-neo were detected in the area of dead cells
with decreased DNA content (Fig. 3). Finally, 24 h after 1
u,M Dex treatment, 80-90% of 2B4-neo underwent DNA
fragmentation and apoptosis, whereas the majority of 2B4-
Bcl-2 (85-95%) were viable (Fig. 4A, lanes 3 and 7). 2B4-
Bcl-2 remained in a growth arrested state until 48 h after Dex
treatment; thereafter cell proliferation ensued at a minimal
level (data not shown). In contrast to Dex treatment, DNA
fragmentation and apoptosis of both 2B4-neo and 2B4-Bcl-2
were induced 24 h after stimulation by anti-CD3e (Fig. 4A,
lanes 2 and 6).
To determine whether transcription factors were selectively
regulated by Bcl-2 after apoptotic signaling, we examined
binding activity of several transcription factors 24 h after Dex
treatment in 2B4-neo and 2B4-Bcl-2. EMSA revealed that AP-
1, LEF-1 and Oct-1 almost completely disappeared from
nuclear extracts of dying 2B4-neo, whereas NF-Y and CREB
remained at relatively high levels (Fig. 4B). By contrast, the
regulation of NF-KB was more complex after Dex treatment.
For 2B4-neo, a strong down-regulation of both NF-KB p65-
p50 and p50-p50 activities was noted, while a new NF-KB-
related band with the intermediate mobility was detected (Fig.
4B, center arrow).
Similar experiments with nuclear extracts from 2B4-Bcl-2
revealed down-regulation of AP-1, Oct-1 and LEF-1, although
changes of these transcription factor levels were not so
dramatic when compared with 2B4-neo. very low levels of
NF-AT activity were detected in 2B4-neo and this binding
activity completely disappeared after Dex treatment. By con-
trast, NF-AT activity was readily detected in untreated 2B4-
Bcl-2 and remained at decreased, but detectable, levels after
Dex treatment (Fig. 4B). The most remarkable changes were
revealed for NF-KB complexes in 2B4-Bcl-2. Similar to 2B4-
neo, the p65-p50 complex was almost undetectable 24
h after Dex treatment of 2B4-Bcl-2, whereas a band with
intermediate mobility was observed. Furthermore, compared
with untreated cells, the level of p50-p50 complex in Dex
treated 2B4-Bcl-2 was obviously up-regulated (Fig. 4B).
The nuclear extracts were pretreated with NF-KB subunit-
specific antibodies prior to EMSA to identify the constituents
of NF-KB complexes. Based on detection of either inhibition
and/or supershift of bands, the upper band mainly was
composed of RelA-p50, the lower complex was p5O-p50 and
the intermediate band was primarily RelB-p50; also there
may be a minor combination of RelB with p52 subunit (Fig.
4C). When RelA-p50 was present at a high level, both RelA-
p50 and RelB-p50 complexes migrate as a single band and
their unambiguous presence was determined by detection of
specific supershifted bands. By this approach, RelB-p50
binding activity was higher for untreated 2B4-Bcl-2 compared
with 2B4-neo. The anti-p50 serum had a pronounced, but not
complete, effect on the inhibition/supershift of the upper
band. This minor resting activity may represent the p65-p52
heterodimer (Fig. 4C).
Time-course studies revealed that down-regulation of the
levels of NF-KB and AP-1 transcription factors were detected
4 h after Dex treatment of 2B4-neo (Fig. 4D) when 90% of
the cells were viable. At 8 h after Dex treatment, low levels
of these factors were observed that correlated with inhibition
of cell growth. By contrast, between 8 and 16 h after Dex
treatment, when 2B4-neo viability dropped dramatically,
increased levels of RelB-p50 activity were detected. For Dex-
treated 2B4-Bcl-2, a decrease in the level of RelA-p50
occurred over time. However, an increase of p50-p50 as well
as RelB-p50 activity was noted between 8 and 16 h (Fig. 3C).
The effects of Bcl-2 on the steady-state levels of NF-KB p50
and RelB proteins and mRNAs
It was somewhat surprising that over-expression of bcl-2 in
2B4 cells resulted in a large increase of NF-KB p50-p50 and
RelB-p50 binding activity considering that the levels of p105
mRNA, that encodes the precursor for NF-KB p50, were similar
for both untreated 2B4-neo and 2B4-Bcl-2. Furthermore, the
levels of NF-KB p105, c-myc, bcl-2 and GAPDH mRNAs
remained constant in 2B4-Bcl-2 up to 16 h after Dex treatment,
whereas c-myc mRNA levels strongly decreased 8 h after
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Dex treatment in control 2B4-neo (see Fig. 1). To determine
whether the increased binding activity of NF-KB p50-p50 and
RelB-p50 reflected an increase in protein levels of p50 and
RelB subunits, Western blot analysis of nuclear proteins was
performed using specific antibodies (Fig. 5). Higher levels of
nuclear RelB protein were detected for 2B4-Bcl-2 than 2B4-
neo with the highest levels seen 8-24 h after Dex treatment
for 2B4-Bcl-2 (Fig. 5A). This increase in RelB nuclear protein
essentially paralleled the binding activity of RelB-p50. By
contrast, the nuclear levels of NF-KB p50 protein detectable
by Western blotting were similar for both 2B4-neo and 2B4-
Bcl-2 prior to Dex treatment (Fig. 5B), although an enhanced
level of NF-KB p50-p50 DNA binding activity was detected
by EMSA for unstimulated 2B4-Bcl-2. This finding suggests
that the high basal level of NF-KB p50-p50 DNA binding
activity in 2B4-Bcl-2 cells may be the result of releasing p50-
p50 from a complex with a nuclear inhibitor without a change
in the total nuclear levels of p50 protein. However, 24 h after
treatment of 2B4-Bcl-2 with Dex, enhanced protein levels of
NF-KB p50 were observed, consistent with increased p50
protein levels accounting for the highest levels of p50-p50
DNA binding activity (Fig. 5B).
NF-KB-dependent transcription in 2B4-neo and 2B4-Bcl-2
Since the EMSA experiments revealed not only up-regulation
of basal levels of RelA-p50 and NF-KB p50-p50 complexes
in 2B4-Bcl-2 cells but also selective regulation of distinct NF-
KB DNA binding complexes after Dex treatment, it was
of interest to examine the net effect on NF-KB-dependent
transcription in these cells. After transient transfection with
the -121-HIV-CAT construct (Fig. 6A), that contained two NF-
KB binding sites, an ~2-fold higher basal level of NF-KB-
dependent transcription occurred for 2B4-Bcl-2 when com-
pared with 2B4-neo. This result correlated with the enhanced
levels of both NF-KB complexes from nuclear extracts of
unstimulated 2B4-Bcl-2, although the magnitude of this
increase was not as substantial as noted for NF-KB DNA
binding activity. Furthermore, after Dex stimulation of 2B4-neo,
a somewhat increased level of NF-KB-dependent transcription
was noted, whereas for 2B4-Bcl-2, Dex treatment resulted
in -2-fold decrease in CAT activity when compared with
unstimulated cells. This result also correlated with the selective
decrease in RelA-p50 and the increase in NF-KB p50-p50
binding activity, which acts as a negative regulator of NF-KB-
dependent transcription. As a positive control for NF-KB-
dependent transcription, anti-CD3e stimulation enhanced CAT
activity for both 2B4-neo and 2B4-Bcl-2 (Fig. 6A). In addition,
no induction of CAT activity was detected for cells transfected
with the -76-HIV-CAT construct, that lacks the NF-KB binding
sites, demonstrating specificity of the assay (not shown).
To further examine the effect of Bcl-2 on regulation of
gene transcription, 2B4-neo and 2B4-Bcl-2 were transiently
transfected with the IL-2-CAT construct (original name pIL-
CAT2/1+) which contains the promoter/enhancer region of
the mouse IL-2 gene, while the variant of this construct
plLCAT2/1 +(205/6A) had mutations in the NF-KB binding site
(32). These constructs were chosen because CAT activity
directed by the IL-2 enhancer is dependent upon binding of
several transcription factors, including NF-KB, NF-AT, AP-1
and Oct (28,33). The inducibility of this enhancer is very
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Fig. 4. Changes in the levels of nuclear transcription factors after
treatment of 2B4-neo and 2B4-Bcl-2 cells with 1 nM Dex. (A) DNA
fragmentation analysis of cytosolic extracts of control and Dex-treated
cells by gel electrophoresis in 1% agarose gel (B) EMSA of nuclear
extracts from indicated cells 24 h after Dex treatment. Specific DNA
binding complexes are shown by arrows. The percentage of viable
cells was determined by Trypan blue exclusion. (C) Identification of
NF-KB DNA binding complexes from untreated or Dex-stimulated
2B4-neo and 2B4-Bcl-2. Nuclear extracts were preincubated before
EMSA with antisera to NF-KB p50, NF-KB p65 (RelA), RelB, c-Rel or
preimmune serum, as indicated above the lanes Bands which were
supershifted with anti-p65 or anti-RelB are design as RelA-ss and
RelB-ss respectively. (D) Time-course analysis of nuclear transcription
factor NF-KB and AP-1 levels by EMSA after Dex treatment
sensitive to the increase in binding activity of nuclear NF-KB
p50-p50 as the NF-KB binding site of the IL-2 promoter has
a very high affinity for NF-KB p50-p50 and low affinity for
RelA-p50 (3,10). For the IL-2-CAT construct (Fig. 6B) CAT
activity was up-regulated in 2B4-neo after anti-CD3e treatment
while co-stimulation with Dex somewhat down-regulated this
induced level. Dex alone slightly increased the basal level of
CAT activity. By contrast, unaltered minimal levels of CAT
activity were detected for 2B4-Bcl-2 after Dex treatment or
anti-CD3e stimulation, probably due to high levels of NF-KB
p50-p50 in the nuclear fraction from these cells. The control
construct with a mutated NF-KB binding site (plLCAT2/1 +(205/
6A) was not inducible in both 2B4-neo and 2B4-Bcl-2 (data
not shown). Furthermore, the level of IL-2 secretion detected
by a standard bioassay was 45-50% less for anti-CD3e-
activated 2B4-Bcl-2 compared with similarly activated 2B4-
oeo»<
Cell death levels of 2B4 clones stably transfected with a NF-
KB p50 expression vector after dexamethasone treatment
To determine whether Bcl-2 regulation of NF-KB p50-p50
levels is directly related to protection of cells from Dex-
induced apoptosis, 2B4 clones were stably transfected with
DEX.
2B4-neo
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Fig. 5. Western blot analysis of RelB (A) and NF-KB p50 proteins (B)
in 2B4-neo and 2B4-Bcl-2 cells after Dex treatment. Nuclear extracts
were prepared at the different time points after Dex treatment of 2B4-
neo and 2B4-Bcl-2 cells as indicated above the lanes. Molecular
weights of the protein markers are shown at the right side.
pRc/CMV-p50, a NF-KB p50 expression vector. Transfected
cells were selected for G418 resistance and expression of
NF-KB p50 mRNA, which was distinguishable from endogen-
ous p105 precursor mRNA by Northern blot analysis. As
shown by EMSA, two clones, 2B4-p50(A9) and 2B4-p50(B4),
were characterized by a 2-fold increase in the nuclear p50-
p50/p65-p50 ratio compared with control 2B4-neo(2) and
2B4-neo(3) cells, which were transfected by vector alone
(Fig. 7A). Cell cycle analysis 16 h after Dex treatment revealed
that the percentage of apoptotic cells with hypodiploid DNA
content was somewhat decreased for 2B4-p50(A9) and 2B4-
p50(B4) compared with control cells, although cell death
levels were higher than observed for 2B4-Bcl-2 cells (Fig.
7B). The average percentage of apoptotic cells from three
experiments was 14 ± 8, 31 ± 10, 42 ± 4 and 53 ± 3%
respectively. These results are consistent with a potential role
of NF-KB p50 in the down-regulation of cell death levels.
Regulation of transcription factor levels in CTLL-2 over-
expressing bcl-2
Previous studies have shown that over-expression of bcl-2 in
the IL-2-dependent CTLL-2 cell line substantially delayed
apoptosis induced by IL-2 withdrawal from culture (22). To
determine whether Bcl-2 also affected transcription factor
binding activities in a cell system other than 2B4, we examined
levels of transcription factors by EMSA for control (CTLL-
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Time-course analysis of transcription factor levels demon-
strated detectable down-regulation of RelA-p50 and NF-KB
p50-p50 levels as early as 2 h after IL-2 withdrawal from
culture when most of the CTLL-neo (95-97%) were viable
(Fig. 8B). The levels of RelA-p50 and AP-1 levels gradually
continued to decline, whereas NF-KB p50-p50 almost disap-
peared 4 h after IL-2 withdrawal from culture. By contrast,
NF-KB p50-p50 levels began to increase for CTLL-Bcl-2 cells
16 h after IL-2 withdrawal from culture. These experiments
indicate that Bcl-2 caused pleiotropic effects on transcription
factors in CTLL-Bcl-2 after apoptotic signaling. Nevertheless,
the common feature of the over-expression of bcl-2 for both
2B4 and CTLL2 was up-regulation of NF-KB p50-p50 levels
after apoptotic signaling that reduced the RelA-p50/p50-p50
ratio, and maintenance of suboptimal levels AP-1, NF-AT and

































Fig. 6. CAT activity directed by NF-KB-dependent CAT construct (A)
and IL-2-CAT (B) in 2B4-neo and 2B4-Bcl-2. Cells were transfected
with -121-HIV-CAT construct containing two NF-KB binding sites (A)
or with IL-2-CAT (B), and then were stimulated with anti-CD3e, Dex
or PMA plus ionomycin as indicated above the lanes. Rsv-p-gal was
used as an internal standard to normalize efficiency of transfection.
One representative experiment of three is shown Average induction
level of CAT activity from three experiments based on the ratio of
conversion of chloramphenicol to its acetylated form is shown at
the bottom
neo) or foc/-2-transfected CTLL-2 (CTLL-Bcl-2). At 24 h after
removal of IL-2 from culture, DNA fragmentation and apoptotic
death of -50% CTLL-neo occurred, whereas the CTLL-Bcl-2
survived and were arrested in the GQ/G, and the G2/M phases
of the cell cycle (22). Down-regulation of several transcription
factors, including RelA-p50, NF-KB p50-p50, AP-1, NF-AT
and Oct-1, was observed for CTLL-neo upon induction of
apoptosis, whereas CREB and NF-Y were readily detected.
The changes in the levels of AP-1 and NF-AT were less
pronounced for CTLL-Bcl-2. Furthermore, RelA-p50 and Oct-
1 were down-regulated while NF-KB p50-p50 and Oct-2 were
substantially up-regulated in CTLL-Bcl-2 (Fig. 8A).
Discussion
Recent studies have established that Bcl-2 functions as an
important factor that represses cell death (13,17) The anti-
apoptotic effect of Bcl-2 has been suggested to ultimately
affect gene regulation in cells by preventing activation of a
key gene(s) that encodes proteins required for programmed
cell death. As a first approximation of this notion, in this study
we have examined the extent by which the expression of bcl-
2 regulates the levels of several transcription factors that are
known to function in T cell activation. Two important points
emerge from this study. First, over-expression of bcl-2 resulted
in pleiotropic effects on transcription factors as the levels of
several transcription factors were enhanced in the untreated
2B4 T cell hybridoma. Second, transcription factors of NF-
KB/Rel family as well as AP-1, NF-AT and Oct were differentially
regulated after 2B4 and CTLL2 received an apoptotic signal.
The 2B4 T cell hybridoma was used as the primary cell
model system since the activation of these cells is well
characterized and 2B4 is susceptible to apoptosis after cross-
linking the TCR or after treatment with PMA and ionomycin,
glucocorticoids or y-irradiation (31,34). Over-expression of
bcl-2 in 2B4 resulted in a large increase in c-myc mRNA and
enhanced basal levels of AP-1, LEF-1, Oct-1 as well as RelA-
p50 and NF-KB p50-p50 nuclear transcription factor binding
activities. These data demonstrated that several transcription
factors that are induced upon TCR stimulation are enhanced
by Bcl-2, presumably due to effects on the intracellular
signaling pathways of Bcl-2. It is clear from our data that
these enhanced transcription factor levels are not a common
property of all T cells that express high levels of Bcl-2.
Although we have noted that untreated £>c/-2-transfected EL4
also contained high constitutive levels of RelA-p50 and NF-
KB p50-p50, the levels of RelA-p50, NF-KB p50-p50 and AP-
1 are high in both control and bc/-2-transfected CTLL. This
finding raises the possibility that the potential effects of Bcl-
2 on preactivation of transcription factors may be related to
a distinct subset of T cells or T cells in a particular phase of
activation or differentiation.
We observed three instances of selective changes in NF-
KB levels in 2B4 and CTLL that raise the possibility that the
NF-KB/Rel family of transcription factors may play an important
Bcl-2 and transcription factors 1717
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Fig. 7 Cell death levels 16 h after Dex treatment of 2B4 clones stably transfected with a NF-KB p50 expression vector. (A) EMSA of nuclear
proteins from 2B4-p50 clones and control cell lines, 2B4-neo(2) and 2B4-neo(3), with labeled probes for NF-KB and NF-Y. (B) Cell cycle
analysis of 2B4-p50 clones. The DNA content in the cells was determined by propidium iodide staining and flow cytometry. Gates M1, M2,
M3 and M4 identify apoptotic cells with hypodiploid DNA content, stages G-i, S and G2/M of the cell cycle respectively. One representative
experiment is shown.
role in regulation of apoptosis First, after 2B4 received an
apoptotic signal via the steroid hormone Dex, RelB DNA
binding activity was induced while all other transcription
factors tested decreased, including RelA-p50 and NF-KB
p50-p50. The presence of RelB might contribute to induction
of new gene transcription, perhaps including a cell death
gene or may promote to the switch from proliferation to cell
arrest. Second, the nuclear levels of RelA-p50 in 2B4-neo and
2B4-Bcl-2 as well as in CTLL-neo and CTLL-Bcl-2 substantially
decreased after the cells received apoptotic signals, whereas
most other transcription factors were maintained at relatively
high levels in the presence of Bcl-2. Lastly, and perhaps most
importantly, the levels of NF-KB p50-p50 binding activity
substantially decreased in 2B4-neo and CTLL-neo shortly
after receiving apoptotic signals. However, p50-p50 activity
significantly increased in 2B4-Bcl-2 and CTLL-Bcl-2 16-24 h
after apoptotic treatment. These latter two findings indicate
that a consequence of high Bcl-2 expression in these cells is
to alter the ratio of NF-KB frans-activators (RelA-p50 and
RelB-p50) to NF-KB p50-p50 frans-inhibitor.
These Bcl-2-induced changes in nuclear factor levels are
functionally relevant since they correlate with the extent
of NF-KB-dependent transcription in vivo. The large basal
increase in nuclear levels of NF-KB p50-p50 after transfection
of 2B4 with bcl-2 was not accompanied by increased levels
of NF-KB p105 mRNA, that encodes the precursor for p50
(7), or increased amounts of nuclear p50 protein. After Dex
stimulation of 2B4-Bcl-2, the levels of p105 mRNA were stable,
although enhanced levels of p50 protein were detected in
the nucleus, which correlated with increase DNA binding
activity. These finding are consistent with a post-transcriptional
mechanism that is primarily responsible for the regulation of
NF-KB p50-p50 via Bcl-2. The increased levels of basal NF-
KB p50-p50 binding activity in nuclear extracts of unstimulated
2B4-Bcl-2 before apoptotic commitment may be explained
by Bcl-2-dependent down-regulation of the protooncogene
bcl-3 as this protein is primarily localized to the nucleus and
functions as an kB-like molecule with high affinity for NF-KB
p50-p50 (11,35,36). Low levels of activity of Bcl-3 or a similar
nuclear iKB-like inhibitor are predicted to lead to higher levels
of uncomplexed nuclear p50-p50 that may result in higher
binding of p50-p50 to DNA without need for increased nuclear
p50 protein. By contrast, the increase in p50-p50 DNA binding
activity upon Dex stimulation cannot be solely accounted for











































1 2 3 4
cell death (%) 0 48 0 2
2 3 6 7 8 9 10 11 12
cell
death (%) 0 3 4 6 37 45 0 0 2 2 1 2
Fig. 8. Changes in the levels of nuclear transcription factors in CTLL-neo and CTLL-Bcl-2 after IL-2 withdrawal from cell culture. (A) EMSA of
nuclear extracts from control cells and cells 24 h after IL-2 withdrawal from culture (IL-2, -) . Specific DNA binding complexes are shown by
arrows. (B) Time-course analysis of NF-KB and AP-1 nuclear transcription factor levels by EMSA after IL-2 withdrawal from culture The
percentage of viable cells was determined by Trypan blue exclusion.
by such a mechanism and may be related to the capacity of
Bcl-2 to increase the processing of the p105 precursor
by the ubiquitin-proteasome pathway (37). Additionally, we
generated 2B4 clones stably transfected with a NF-KB p50
expression vector. As the nuclear ratio of p50-p50/p65-p50
was increased in these cells, elevated levels of cell survival
were noted after Dex treatment. These experiments suggest
that regulation of NF-KB p50-p50 levels is directly related to
cells surviving after apoptotic signaling.
It is highly likely that Bcl-2 interacts at several levels with
the intracellular signaling pathways to regulate the levels of
NF-KB and other transcription factors. Simply considering NF-
KB, there are several examples whereby expression of bcl-2
affects cellular activity that may be expected to lead to
regulation of the levels of NF-KB. This includes the antioxidant
effect of Bcl-2 (18,19) and the ability of Bcl-2 to associate
with R-Ras (38) and Raf-1 (39), which are critical elements in
several signaling pathways, including one that regulates
activation of RelA-p50. Furthermore, Bcl-2 has been shown
to repress apoptosis by inhibition of endoplasmic reticulum-
associated Ca2+ fluxes (40), while the release RelA-p50 from
IKB is partially dependent upon Ca2+ (41). It is obvious that
the ability of Bcl-2 to affect an intracellular second messenger
as Ca2+ or a down-stream signaling protein such as R-Ras
and Raf-1 is almost certain to lead to regulation of multiple
transcription factors in the cell. The pleiotropic effects on
transcription factors we have noted here support this view.
However, our data have not confirmed a direct antioxidant
function of Bcl-2 on transcription factor regulation. In fact, we
observed preactivation rather than inactivation of NF-KB and
LEF-1, which is characteristic for antioxidant action (3,20). An
observed preactivation of several transcription factors in the
presence of Bcl-2 in 2B4 without any external stimulation
appears to correspond to the recently identified pro-oxidant
function of Bcl-2 (42).
Suppression of c-myc expression has been proposed as a
critical step in glucocorticoid-induced apoptosis (43). The
enhanced levels of c-myc mRNA in 2B4-Bcl-2 may be function-
ally relevant since in some cases Bcl-2 cooperates with c-
Myc to overcome cell growth arrest (44). However, it should
be stressed that c-Myc plays a di.stinct role in glucocorticoid-
induced and activation-induced apoptosis. In the latter case,
c-Myc promotes cell death (45). Furthermore, c-myc transcrip-
tion is in part dependent upon NF-KB/Rel factors (46). Sup-
pression of c-myc expression after Dex treatment of 2B4 and
the absence of suppression in i>c/-2-transfected cells may be
regulated by differential effects of Bcl-2 on NF-KB/Rel factor
activities after receiving apoptotic signals.
Our data has not established a direct role for NF-KB-
dependent transcription in the regulation of cell death genes.
However, the induction of RelB in 2B4 upon receiving an
apoptotic signal and the selective inducible increase in NF-
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tcB p50-p50 by £>c/-2-transfected 2B4 which was resistant to
apoptosis strongly suggest that the NF-tcB/Rel family is a
prime candidate for transcription factors that participate in
the regulation of apoptosis. Our working model is that upon
receiving an apoptotic signal, NF-icB/Rel factors contribute to
the induction of transcription of one or more key genes
important for cell death of 2B4. One aspect of the anti-
apoptotic function of Bcl-2 is to regulate NF-KB in a manner
to inhibit expression of this gene by enhancing the nuclear
levels of NF-tcB p50-p50, which has been shown to represent
DNA binding, but not frans-activating, function and sometimes
serves as a very potent suppressor of NF-icB-dependent
transcription (10-12). Although RelB was not detected in
CTLL2 upon induction of apoptosis by IL-2 withdrawal, disbal-
ance of the RelA-p50/p50-p50 ratio by increasing NF-KB
p50-p50 levels in CTLL-Bcl-2 also correlated with suppression
of apoptosis.
It is also clear from our data that the second aspect of anti-
apoptotic effect of Bcl-2 is likely to involve other transcription
factors, especially AP-1, that regulates genes which may not
be dependent upon NF-KB. Transcription factors of the AP-1
family as well as c-Myc participate in the control of cell
proliferation by an unknown mechanism (43,47,48). The
observed down-regulation of AP-1 levels as a result of Dex
treatment or absence of IL-2-dependent signals correlates
with inhibition of cell proliferation. Others have shown a
direct physical interaction between activated glucocorticoid
receptor and the Jun subunit of AP-1 (49) or between gluco-
corticoid receptor and the NF-KB p65 and p50 subunits
(50,51) that strongly inhibited specific AP-1 and NF-KB binding
activities after Dex treatment. If such glucocorticoid receptor-
mediated interaction in the absence of Bcl-2 caused cell
death (14), over-expression of Bcl-2 promotes cell survival
by the maintenance of minimal levels of several key transcrip-
tion factors.
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